Here's your complete MS1-level anemia outline drawn directly from Robbins, Cotran & Kumar and Guyton & Hall:
Anemia — Detailed MS1 Outline
Robbins, Cotran & Kumar — Pathologic Basis of Disease | Guyton & Hall — Medical Physiology
SECTION 1: DEFINITION & OVERVIEW
Anemia = reduction of the total circulating red cell mass below normal limits → decreased oxygen-carrying capacity → tissue hypoxia.
Diagnosed clinically by:
- ↓ Hematocrit (packed RBC volume / total blood volume)
- ↓ Hemoglobin concentration (g/dL)
"Anemia means deficiency of hemoglobin in the blood, which can be caused by too few RBCs or too little hemoglobin in the cells." — Guyton & Hall
SECTION 2: CLASSIFICATION
2A. By Mechanism (Robbins — Table 14.1)
| Mechanism | Examples |
|---|
| Blood loss | Acute (trauma), Chronic (GI bleed, menorrhagia) |
| ↑ Destruction (Hemolysis) | Spherocytosis, G6PD, Sickle cell, Thalassemia, PNH, Autoimmune HA |
| ↓ Production | Iron deficiency, Megaloblastic, Aplastic, Anemia of chronic disease |
2B. By Morphology (Peripheral Smear — Clinically Useful)
| Morphology | MCV | Causes |
|---|
| Microcytic hypochromic | < 80 fL | Iron deficiency, Thalassemia, Anemia of chronic disease |
| Normocytic normochromic | 80–100 fL | Acute blood loss, Aplastic anemia, Hemolysis, CKD |
| Macrocytic | > 100 fL | Megaloblastic (B12/folate deficiency), Liver disease, Hypothyroidism |
Key Red Cell Indices
| Index | Normal | What it Measures |
|---|
| MCV | 80–100 fL | Average RBC size |
| MCH | 27–33 pg | Hemoglobin per RBC |
| MCHC | 32–36 g/dL | Hemoglobin concentration in RBCs |
| RDW | < 14.5% | Variation in RBC size (↑ in iron deficiency) |
SECTION 3: HEMOLYTIC ANEMIAS (Increased Destruction)
Key concept: Hemolysis = RBC destruction before normal 120-day lifespan. Can be intravascular (within blood vessels) or extravascular (in spleen/liver macrophages — most common).
Lab hallmarks of hemolysis:
- ↓ Hb, ↓ Hematocrit
- ↑ Reticulocytes (compensatory BM response)
- ↑ Unconjugated (indirect) bilirubin → jaundice
- ↑ LDH (cell lysis marker)
- ↓ Haptoglobin (binds free Hb — gets consumed)
- Splenomegaly (from RBC trapping)
3A. HEREDITARY SPHEROCYTOSIS (HS)
Category: Inherited red cell membrane disorder
Pathogenesis
- Autosomal dominant (AD) in most; some AR
- Mutations in RBC cytoskeletal proteins:
- Ankyrin (most common), Spectrin (α or β), Band 3, Protein 4.2
- These proteins anchor the lipid bilayer to the underlying cytoskeleton
- Deficiency → membrane instability → RBC loses membrane fragments during repeated splenic passage (vesiculation)
- Surface area ↓ relative to volume → sphere shape (spherocyte) instead of biconcave disc
- Spherocytes are rigid → trapped in splenic sinusoids → destroyed by macrophages = extravascular hemolysis
"The RBCs are very small and spherical rather than biconcave discs. They cannot withstand compression forces because they do not have the normal loose, baglike membrane structure." — Guyton & Hall
Peripheral Smear
- Small, round, dark-staining spherocytes with no central pallor
Diagnosis
- Osmotic fragility test — spherocytes lyse in hypotonic saline more readily (↑ fragility)
- EMA binding test (flow cytometry) — modern, more sensitive
- Negative direct Coombs test (distinguishes from autoimmune HA)
Clinical Features
- Anemia (variable severity), Jaundice, Splenomegaly
- Pigment gallstones (excess bilirubin → calcium bilirubinate stones)
- Aplastic crisis — triggered by Parvovirus B19 (kills erythroid precursors → sudden severe anemia)
- Megaloblastic crisis — folate demand exceeds supply
Treatment
- Splenectomy — removes site of destruction → cures anemia (spherocytes persist on smear, but no longer destroyed)
- Folic acid supplementation
3B. G6PD DEFICIENCY
Category: Inherited enzyme defect (hexose monophosphate / pentose phosphate shunt)
Pathogenesis
- X-linked recessive → mainly affects males
- G6PD = first enzyme of the HMP shunt → generates NADPH → keeps glutathione (GSH) in reduced form
- GSH = RBC's primary antioxidant (neutralizes H₂O₂ and superoxide)
- Without G6PD → NADPH depleted → GSH depleted → oxidative stress unchecked
- Oxidized hemoglobin denatures → forms Heinz bodies (precipitates on RBC membrane)
- Macrophages "bite out" Heinz bodies → bite cells / blister cells on smear
- Eventually → episodic hemolysis triggered by oxidative stressors
Triggers
| Category | Examples |
|---|
| Drugs | Primaquine, dapsone, sulfonamides, nitrofurantoin |
| Infections | Any febrile illness |
| Foods | Fava beans (favism — esp. Mediterranean variant) |
| Metabolic | DKA (acidosis) |
Key Variants
| Variant | Population | Severity |
|---|
| G6PD A− | African Americans | Mild — only old RBCs affected (young RBCs still have enzyme) |
| G6PD Mediterranean | Mediterranean, Middle East | Severe — all RBCs affected |
Peripheral Smear During Crisis
- Bite cells / blister cells
- Heinz bodies (seen with crystal violet stain, not standard H&E)
- Polychromasia (reticulocytosis)
Diagnosis
- G6PD enzyme assay — best done after crisis (during crisis, deficient old cells are destroyed; only young cells with higher enzyme remain → may give false-normal result)
Clinical Features
- Between episodes: Completely normal
- During episode: Acute hemolytic anemia, dark urine (hemoglobinuria), jaundice, back/abdominal pain
- Self-limiting in G6PD A− (new young RBCs replace old ones); more severe in Mediterranean variant
Treatment
- Avoid triggers (primary prevention)
- Supportive care during crisis; transfusion if severe
3C. SICKLE CELL DISEASE (SCD)
Category: Hemoglobinopathy (structurally abnormal globin)
Molecular Basis
- Autosomal recessive (codominant)
- Single point mutation in β-globin gene (chromosome 11):
→ Position 6: Glutamic acid → Valine
→ Normal HbA (α₂β₂) → HbS (α₂β^S₂)
- HbSS = sickle cell disease (severe)
- HbAS = sickle cell trait (asymptomatic, protective against P. falciparum malaria)
Mechanism of Sickling
- Deoxygenation → HbS polymerizes into long rigid tactoids (fibers)
- RBC distorts into a sickle/crescent shape
- Initially reversible (re-oxygenation un-sickles); repeated episodes → irreversibly sickled cells (permanent membrane damage)
- Sickled cells:
- Are rigid → obstruct microvessels → vaso-occlusion → ischemia/infarction
- Are fragile → destroyed by spleen → hemolysis
Factors that promote sickling: ↓ O₂ tension, dehydration, acidosis, cold, infection, high altitude
"The precipitated hemoglobin damages the cell membrane, so the cells become highly fragile, leading to serious anemia." — Guyton & Hall
Clinical Features
From Hemolysis:
- Chronic hemolytic anemia (Hb 6–9 g/dL), jaundice, gallstones, splenomegaly (early)
- Aplastic crisis (Parvovirus B19)
From Vaso-occlusion (Ischemia/Infarction):
| Organ | Manifestation |
|---|
| Bone/marrow | Painful vaso-occlusive crises (most common symptom — "bone pain") |
| Spleen | Autosplenectomy — repeated infarcts → fibrosed shrunken spleen → ↑ risk of encapsulated bacteria |
| Lung | Acute chest syndrome — fever, chest pain, ↓ SpO₂ — leading cause of death |
| Brain | Stroke — especially in children |
| Kidney | Renal papillary necrosis, isosthenuria (can't concentrate urine) |
| Bones | Dactylitis (hand-foot syndrome in infants), avascular necrosis of femoral head |
| Eyes | Proliferative retinopathy |
| Penis | Priapism |
| Skeleton | "H-shaped" vertebrae on X-ray (vertebral body infarcts) |
Peripheral Smear
- Sickle cells (crescent-shaped), target cells
- Howell-Jolly bodies (nuclear remnants — normally removed by spleen; present after autosplenectomy)
- ↑ Reticulocytes
Diagnosis
- Hemoglobin electrophoresis (gold standard) — HbS band present, HbA absent in HbSS
- HPLC (newborn screening)
- Sickling test (sodium metabisulfite)
Treatment
- Hydroxyurea — ↑ HbF production (HbF inhibits HbS polymerization → ↓ sickling, ↓ crises)
- Penicillin prophylaxis (for asplenic patients)
- Vaccinations (pneumococcal, meningococcal, H. flu)
- Folic acid supplementation
- Exchange transfusion (acute chest syndrome, stroke)
- Bone marrow transplantation (curative)
3D. THALASSEMIA
Category: Hemoglobinopathy — deficient globin chain synthesis
Normal Hb: α₂β₂ (HbA). Thalassemias = ↓ synthesis of one globin chain → the other accumulates → precipitates → damages RBCs.
β-Thalassemia
- Mutations in β-globin gene (chromosome 11) — mostly point mutations (>200 known)
- β⁰ = no β-chain produced; β⁺ = reduced β-chain produced
- ↓ β-globin → excess α-chains accumulate → precipitate as inclusions → damage RBC membrane → ineffective erythropoiesis (death of precursors in BM) + hemolysis
- Compensatory massive erythropoiesis → bone marrow expansion → skeletal deformities
| Genotype | Syndrome | Severity |
|---|
| β/β | Normal | — |
| β/β⁺ or β/β⁰ | β-Thalassemia Minor (Trait) | Mild microcytosis, clinically silent |
| β⁺/β⁺ | β-Thalassemia Intermedia | Moderate anemia, variable transfusion need |
| β⁰/β⁰ | β-Thalassemia Major (Cooley's anemia) | Severe, transfusion-dependent from 6 months |
β-Thalassemia Major Clinical Features:
- Severe hemolytic anemia appearing at 6 months (HbF → HbA switch)
- Massive hepatosplenomegaly (extramedullary hematopoiesis)
- "Crew-cut" skull X-ray (expanded diploe — perpendicular trabeculae)
- Chipmunk facies (maxillary bone overgrowth)
- Growth retardation
- Iron overload (from transfusions + ↑ GI absorption) → hemosiderosis → heart failure, cirrhosis, endocrine failure (the main cause of death)
- Lab: ↑ HbF, absent/↓ HbA, ↑ HbA₂
Treatment: Regular transfusions + iron chelation (deferoxamine/deferasirox); BMT (curative)
α-Thalassemia
- Deletions in α-globin genes (chromosome 16) — normal = 4 α-genes
| Deletions | Syndrome | Features |
|---|
| 1 gene deleted | Silent carrier | Normal |
| 2 genes deleted | α-Thalassemia trait | Mild microcytic anemia |
| 3 genes deleted | HbH disease | Moderate hemolytic anemia; excess β-chains → HbH (β₄) |
| 4 genes deleted | Hydrops fetalis | Incompatible with life; excess γ-chains → Hb Bart's (γ₄) — can't deliver O₂ |
3E. AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
| Type | Antibody | Temperature | Causes |
|---|
| Warm AIHA | IgG | 37°C | Idiopathic, SLE, CLL, drugs (methyldopa) |
| Cold AIHA | IgM | < 30°C | Mycoplasma, EBV, idiopathic |
Diagnosis: Direct Coombs test (DAT) — positive
Treatment: Corticosteroids (warm), cold avoidance, rituximab
3F. PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
- Acquired mutation in PIG-A gene → loss of GPI-anchor proteins (CD55, CD59)
- CD55/CD59 normally protect RBCs from complement attack
- Without them → complement destroys RBCs → intravascular hemolysis
- Classic triad: hemolytic anemia + thrombosis (unusual sites: hepatic vein) + cytopenias
- Hemoglobinuria worst in morning (acidosis during sleep → complement activation)
- Diagnosis: Flow cytometry (loss of CD55/CD59)
- Treatment: Eculizumab (anti-C5 complement inhibitor)
SECTION 4: ANEMIAS OF DIMINISHED ERYTHROPOIESIS
4A. IRON DEFICIENCY ANEMIA — Most common anemia worldwide
Iron Metabolism
- Absorbed in duodenum/proximal jejunum (needs acidic pH; enhanced by vitamin C; inhibited by phytates, tea)
- Stored as ferritin (soluble) and hemosiderin (insoluble) in liver, spleen, marrow
- Transported by transferrin in plasma
Causes
| Category | Examples |
|---|
| Chronic blood loss (most common in adults) | GI bleeding (peptic ulcer, colorectal cancer), menorrhagia |
| Inadequate intake | Poor diet, infancy, pregnancy |
| Malabsorption | Celiac disease, post-gastrectomy, achlorhydria |
⚠️ "An alert clinician investigating unexplained iron deficiency anemia occasionally discovers an occult bleeding source such as cancer and thereby saves a life." — Robbins & Cotran
Lab Findings
| Test | Iron Deficiency Anemia |
|---|
| Serum iron | ↓ |
| TIBC | ↑ (body makes more transferrin to grab every iron molecule) |
| Serum ferritin | ↓↓↓ (earliest and most sensitive marker) |
| Transferrin saturation | ↓ (< 15%) |
| MCV | ↓ (microcytic) |
| MCHC | ↓ (hypochromic) |
| RDW | ↑ (high variation in cell size) |
| Reticulocytes | Low (production failure) |
Stages of Depletion
- Pre-latent: Stores depleted (↓ ferritin), normal Hb
- Latent: ↓ serum iron, ↑ TIBC, normal Hb
- IDA: Microcytic hypochromic anemia appears
Clinical Features
- Fatigue, pallor, exertional dyspnea
- Pica — craving for non-food items (ice, clay)
- Koilonychia — spoon-shaped nails
- Angular stomatitis, atrophic glossitis
- Plummer-Vinson syndrome — IDA + esophageal webs + dysphagia (→ ↑ risk esophageal carcinoma)
Treatment
- Find and treat underlying cause
- Oral ferrous sulfate for 3–6 months (continue 3 months after Hb normalizes to replenish stores)
- IV iron (malabsorption, intolerance, severe)
- Reticulocyte response in 5–10 days = confirms diagnosis
4B. MEGALOBLASTIC ANEMIA (Vitamin B12 / Folate Deficiency)
Core Concept
Both B12 and folate needed for DNA synthesis (thymidylate production). Deficiency → cells grow but cannot divide → large immature cells = megaloblasts in BM → macrocytes in blood. All rapidly dividing cells affected (including neutrophils → hypersegmented neutrophils).
"The RBCs grow too large, with odd shapes, and are called megaloblasts... the cells are mostly oversized, have bizarre shapes, and fragile membranes." — Guyton & Hall
Vitamin B12 Deficiency
Absorption pathway:
Dietary B12 (animal products) → binds Intrinsic Factor (IF) from gastric parietal cells → B12-IF complex absorbed at terminal ileum
Causes:
| Cause | Example |
|---|
| ↓ IF | Pernicious anemia (autoimmune — anti-parietal cell Ab, anti-IF Ab), total gastrectomy |
| ↓ Ileal absorption | Crohn's disease (terminal ileum), ileal resection, fish tapeworm (Diphyllobothrium) |
| ↓ Dietary intake | Strict vegans (body stores last 3–5 years) |
Pernicious Anemia (most important cause):
- Autoimmune destruction of parietal cells
- Anti-parietal cell antibodies (destroy the cells); anti-IF antibodies (block B12-IF binding)
- Associated with Hashimoto's thyroiditis, T1DM
- ↑ risk of gastric adenocarcinoma
Unique to B12 deficiency (not folate):
- Subacute combined degeneration of the spinal cord — degeneration of dorsal columns (vibration/proprioception loss) + lateral corticospinal tracts (upper motor neuron signs) + peripheral neuropathy
- Neurological damage progresses even if hematologic anemia is "corrected" by giving folate alone → dangerous
Folate Deficiency
Causes:
- Poor diet (alcoholics, elderly, overcooking vegetables)
- ↑ Demand (pregnancy, hemolytic anemia, rapid growth)
- Malabsorption (celiac disease)
- Drugs: Methotrexate, trimethoprim, phenytoin (folate antagonists)
⚠️ Folate in pregnancy: Deficiency → neural tube defects (spina bifida, anencephaly). Supplement from before conception.
Lab Findings (Both B12 and Folate)
| Test | Finding |
|---|
| MCV | > 100 fL (macrocytic) |
| Peripheral smear | Hypersegmented neutrophils (≥5 lobes or ≥1 cell with 6 lobes) — pathognomonic |
| Bone marrow | Megaloblasts, giant bands |
| Serum B12 | ↓ in B12 deficiency |
| Serum/RBC folate | ↓ in folate deficiency |
| Homocysteine | ↑ in both |
| Methylmalonic acid (MMA) | ↑ in B12 only — key differentiator |
Treatment
- B12: IM cyanocobalamin (oral ineffective in pernicious anemia/malabsorption)
- Folate: Oral folic acid
- ⚠️ Never give folate alone if B12 deficiency suspected — corrects blood picture but neurological damage continues
4C. APLASTIC ANEMIA
Definition: Hypocellular bone marrow → pancytopenia (↓ RBCs + ↓ WBCs + ↓ platelets)
Causes
| Type | Mechanism | Examples |
|---|
| Acquired (>80%) | T-cell mediated autoimmune destruction of hematopoietic stem cells | Idiopathic (50%), drugs (chloramphenicol, benzene), radiation, viral (hepatitis, EBV) |
| Inherited | Genetic defects | Fanconi's anemia (AR, DNA repair defect — short stature, radial defects, ↑ risk of AML) |
"Exposure to high-dose radiation or chemotherapy... damage stem cells of the bone marrow... insecticides or benzene in gasoline may cause the same effect." — Guyton & Hall
Lab Findings
- Pancytopenia
- Hypocellular bone marrow with fatty replacement (> 70% fat on biopsy) — diagnostic
- ↓ Reticulocytes (production failure)
- Normal RBC morphology
Clinical Features
- Anemia symptoms (fatigue, pallor)
- Infections (from neutropenia — most life-threatening)
- Bleeding (thrombocytopenia — petechiae, ecchymoses)
Treatment
- Severe + young with matched donor: Bone marrow transplantation (curative)
- Severe without donor: Immunosuppression (anti-thymocyte globulin + cyclosporine + eltrombopag)
- Supportive: transfusions, G-CSF
4D. ANEMIA OF CHRONIC DISEASE (ACD)
Most common anemia in hospitalized patients
Pathogenesis
- Chronic infection / autoimmune disease / cancer → chronic inflammation → IL-6 → ↑ hepcidin (liver-derived)
- Hepcidin degrades ferroportin (iron exporter on macrophages and gut enterocytes)
- Result: iron trapped in macrophage stores, ↓ GI iron absorption → functional iron deficiency (iron present but not accessible for erythropoiesis)
- Also: ↓ EPO response, ↓ RBC lifespan
Key Lab Comparison
| Test | ACD | Iron Deficiency |
|---|
| Serum iron | ↓ | ↓ |
| TIBC | ↓ or normal | ↑ |
| Ferritin | ↑ | ↓↓↓ |
| Transferrin saturation | ↓ | ↓ |
"Storage iron in the bone marrow and serum ferritin are increased [in ACD], in contrast to iron deficiency anemia." — Robbins & Cotran
Treatment
- Treat underlying disease
- ESAs (erythropoietin-stimulating agents) in CKD
- IV iron if also functionally iron-depleted
SECTION 5: PHYSIOLOGICAL EFFECTS OF ANEMIA — Guyton & Hall
Cardiovascular Compensation
- ↓ Blood viscosity → ↓ peripheral resistance → ↑ cardiac output (↑ HR + ↑ SV)
- Chronic severe anemia → high-output state → heart failure
- Vasodilation from tissue hypoxia-induced local mediators
O₂ Delivery Compensation
- ↑ 2,3-BPG (DPG) in RBCs → right-shifts O₂-Hb dissociation curve → Hb releases O₂ more easily to tissues
- ↑ O₂ extraction fraction per unit blood
Erythropoietin Response
- Kidney peritubular cells sense ↓ O₂ → ↑ EPO → BM → ↑ erythroid progenitor proliferation → ↑ reticulocyte release
- Reticulocyte response begins in 3–5 days, peaks at 7–10 days
Symptoms by Severity
| Hb (g/dL) | Typical Symptoms |
|---|
| 10–12 | Fatigue on exertion, mild pallor |
| 7–10 | Exertional dyspnea, tachycardia, palpitations |
| < 7 | Rest dyspnea, angina (if CAD), heart failure, CNS symptoms |
| < 5 | Life-threatening cardiac decompensation |
SECTION 6: MASTER COMPARISON TABLE
| Feature | Hereditary Spherocytosis | G6PD Deficiency | Sickle Cell | β-Thal Major | Iron Deficiency | B12/Folate | Aplastic |
|---|
| Inheritance | AD | X-linked recessive | AR | AR | Acquired | Acquired | Acquired |
| Defect | Membrane (ankyrin, spectrin) | Enzyme (HMP shunt) | Hb structure (Glu→Val) | Hb synthesis (β↓) | Iron supply | Vitamin (DNA synthesis) | Stem cells |
| MCV | Normal/slight ↓ | Normal | Normal | Microcytic ↓↓ | Microcytic ↓↓ | Macrocytic ↑↑ | Normal |
| Smear finding | Spherocytes | Bite cells, Heinz bodies | Sickle cells, targets, HJ bodies | Targets, nucleated RBCs, teardrop cells | Pencil cells, microcytes | Hyperseg. neutrophils | Normal morphology |
| Hemolysis type | Extravascular | Intra + extravascular | Both | Extravascular + ineffective erythropoiesis | None | None | None |
| Splenomegaly | ✓ | — | Early ✓ → autosplenectomy | Massive ✓ | — | — | — |
| Key diagnostic test | Osmotic fragility / EMA flow | G6PD enzyme assay | Hb electrophoresis | Hb electrophoresis | Ferritin ↓↓, TIBC ↑ | MMA ↑ (B12), homocysteine ↑ | BM biopsy (hypocellular) |
| Key treatment | Splenectomy | Avoid triggers | Hydroxyurea | Transfusion + iron chelation | Oral iron | IM B12 / oral folate | BMT / immunosuppression |
SECTION 7: MEMORY AIDS
| Topic | Mnemonic / Trick |
|---|
| G6PD mechanism | "No G6PD → No NADPH → No GSH → No antioxidant → Oxidative crisis → Heinz bodies → Bite cells" |
| IDA vs. ACD | Ferritin is the key: ↓ in IDA (stores empty), ↑ in ACD (stores full but locked) |
| B12 vs. Folate | Both: macrocytic anemia + hyperseg neutrophils. Only B12: neurological damage (subacute combined degeneration) + ↑ MMA |
| α-thal chromosomes | Alpha = chromosome 16 (A is the 1st letter); Beta = chromosome 11 (B is 2nd letter) |
| Sickle cell trait | HbAS = Asymptomatic + Anti-malarial (protective against P. falciparum) |
| Splenectomy in HS | Removes the "execution chamber" — spherocytes persist on smear but survive longer |
| Pernicious anemia | Parietal cells make IF; if destroyed → no IF → no B12 absorption from terminal ileum |
| Thalassemia major skeleton | "Crew-cut skull, chipmunk face, H-vertebrae" = all from marrow expansion/infarction |
Sources: Robbins, Cotran & Kumar — Pathologic Basis of Disease, Ch. 14; Robbins & Kumar Basic Pathology, Ch. 13; Guyton and Hall Textbook of Medical Physiology, Ch. 33 (Red Blood Cells, Anemia, and Polycythemia).